Graphite buys Random42

Financial details were not disclosed. Graphite invested via Graphite Capital Partners VIII, which closed on £475m in 2013. The vehicle targets buyouts of UK-based businesses valued in the £40-150m range.

Crescent Capital Group and HSBC provided a debt financing package for the transaction.

Vespa Capital invested in Random42, a London-based supplier of 3D medical animation software to the pharmaceutical and biotech sectors, in early 2015. The fresh capital was earmarked to fund the company's further expansion in its existing international markets, including North America and Japan.

In a statement, Graphite stated that the medical animation market is forecast to grow strongly, with Random42’s core pharmaceutical market expected to grow to more than £100m by 2021.

Random42 will look to increase its geographic coverage by expanding in Europe and the Far East, while continuing to grow its core North American sales. The company will also consider new markets including educational materials, corporate promotions, animal health, over-the-counter drugs and medical devices.

Company
Founded in 1991 and headquartered in London, Random42 develops 3D medical animation software for the pharmaceutical and biotech sectors. Its clients include AstraZeneca, Roche, GlaxoSmithKline and Novartis.

Random42 posted a £7.5m turnover for the year ending in April 2017.

People
Graphite Capital - Andy Gray, Markus Golser, Humphrey Baker, Liam McGivern, John Western, Sophie Davies.

Advisers
Equity - DC Advisory, David Sanders, Leo Todd (corporate finance); Lincoln International, Jonathan Broome, Vangelis Livanis (debt advisory); Travers Smith, Paul Dolman, Will Yates (legal); PwC – Jonathan Cooper, Graeme Hurst, Barry Jaber, David Smith, Andrew Turner, Peter Renon, Andrew Smith, Ben Smith (financial due diligence, IT due diligence, commercial due diligence, tax); AJ Gallagher, George Minoprio (insurance due diligence).
Vendors - KPMG, David Elms, Ed Wirgman (corporate finance); DLA Piper, Tim Lake (legal); Plural Strategy, Jim Eastern, Jamie Berridge (commercial due diligence).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Exits
• UK / Ireland
• Technology
• Graphite Capital
• Vespa Capital
• Secondary buyout